Packaging Information. Packages will consist of one Dose per package. The package design for the Product will be IAEA compliant Type A packaging for international transportation. BIOMEDICA is solely responsible for compliance of the text of the package labels with applicable regulations in the Territory countries for both the Product and the Compound. It is the intent of the Parties that the package label will indicate BIOMEDICA as the Party for whom the Compound and/or Product is manufactured.
Appears in 2 contracts
Sources: Supply Agreement (Molecular Insight Pharmaceuticals, Inc.), Supply Agreement (Molecular Insight Pharmaceuticals, Inc.)